Clinical Trial Update: Quality of Life and Cardiometabolic Risk Factors in Patients After Debanding

View source ↗

Summary

A completed study from the University of Zurich evaluated quality of life and cardiometabolic risk factors in bariatric patients after debanding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Snippet

Sponsor: University of Zurich | Conditions: Bariatric Patients | Status: COMPLETED